Search

everythinglearnresearchcommunity

for

Search:↓

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Calancardin B may help reduce inflammation in immune cells.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

An injectable ibuprofen gel speeds up diabetic wound healing by reducing inflammation and promoting tissue growth.

NIPP1 is important for healthy skin and could help treat skin inflammation.

Skin inflammation can worsen intestinal inflammation and colitis.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

The new gel effectively treats MRSA-infected wounds for longer.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Six existing drugs may help block virus entry in COVID-19.

TREM2 macrophages and unsaturated lipids contribute to acne inflammation.

Invasomes effectively deliver drugs through the skin and have potential for improved treatments.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Cardamonin reduces inflammation in gum tissue cells.